Breaking News Instant updates and real-time market news.

MDR

McDermott

$0.80

-0.0069 (-0.86%)

07:00
12/02/19
12/02
07:00
12/02/19
07:00

McDermott, Chiyoda introduce feed cast to Train 2 at Cameron LNG

McDermott and its joint venture partner, Chiyoda International Corporation, a U.S.-based wholly-owned subsidiary of Chiyoda Corporation, Japan, announced that Train 2 of the Cameron project, located in Hackberry, LA, has reached the final commissioning stage. This includes the introduction of pipeline feed gas into Train 2 of the liquefaction export facility, the precursor for the production of liquefied natural gas, or LNG. This achievement is yet another significant milestone during 2019 and the first for Train 2. McDermott announced introduction of feed gas to Train 1 on April 15, 2019, which was followed by first liquid on May 14 and first cargo from Train 1 on May 31. On August 19, Cameron LNG announced that Train 1 began commercial operation, following its substantial completion.

MDR McDermott
$0.80

-0.0069 (-0.86%)

09/11/19
SBSH
09/11/19
NO CHANGE
Target $7
SBSH
Neutral
McDermott price target lowered to $7 from $11 at Citi
Citi analyst Andrew Kaplowitz lowered his price target for McDermott to $7 from $11 while keeping a Neutral rating on the shares. While the analyst sees "some light at the end of the tunnel" for the company on its two "troublesome" liquefied natural gas projects and believes the negative estimate revisions for CBI Legacy work may be behind the company, he says he can't rule out "further project-related noise." Further, McDermott's balance sheet is still relatively levered and some uncertainty regarding the timing of asset sales remains, Kaplowitz tells investors in a research note.
09/19/19
SBSH
09/19/19
NO CHANGE
Target $7
SBSH
Neutral
Citi sees working capital unwind as 'legitimate risk' for McDermott
Shares of McDermott dropped 63% yesterday following news that the company hired turnaround firm AlixPartners for "strategic and operational advice." Low liquidity, high leverage, and lingering headwinds associated with legacy CB&I-related projects pose elevated risk for the company, Citi analyst Andrew Kaplowitz tells investors in a research note. The analyst admits that he does not know what's causing McDermott to turn to AlixPartners. He sees a "wide range of possibilities with little visibility to near-term outcomes," which leads to his continued Neutral rating on the shares. McDermott has a "considerable amount of good assets" that are saleable and customers have an incentive to see the company succeed, says Kaplowitz. However, a working capital unwind is now a "legitimate risk" and it may be harder for McDermott to win work at this point, adds the analyst.
09/20/19
FBCO
09/20/19
NO CHANGE
Target $7
FBCO
Neutral
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
Credit Suisse analyst Jamie Cook says McDermott's announcement that it will explore selling its Lummus technology business was considered "a last resort," but was "unfortunately needed" to improve the balance sheet. Cook, who maintains a Neutral rating and $7.00 price target, says she believes McDermott would prefer to retain some ownership in order to retain rights to be the first bidder on the EPC business if possible. She feels a transaction could occur "quickly," given the asset was already on the market recently and says she believes the stock should rally on this news given the dramatic sell off this week and that management is not considering chapter 11.
11/05/19
SBSH
11/05/19
NO CHANGE
Target $1.6
SBSH
Neutral
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
Citi analyst Andrew Kaplowitz lowered his price target for McDermott International to $1.60 from $2.00 and keeps a Neutral rating on the shares. The stock closed yesterday up 6c to $1.76. The company's risks continue to rise following its "disappointing" Q3 results, Kaplowitz tells investors in a research note. With continued deterioration in cash, McDermott's bankruptcy risk is rising as the company stated in its quarterly filing that "there is substantial doubt regarding our ability to continue as a going concern," the analyst points out. While Kaplowitz continues to see value in McDermott' technology asset and believes it can be sold for $2.5B through competitive bidding, he sees rising uncertainty surrounding the company's future operation.

TODAY'S FREE FLY STORIES

XLU

Utilities SPDR

$62.98

-0.005 (-0.01%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$62.52

-0.24 (-0.38%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$304.54

2.52 (0.83%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Conference/Events
Cooper Companies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

XLV

Health Care Select Sector SPDR

$99.86

0.14 (0.14%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$162.58

0.11 (0.07%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDS

HD Supply

$39.07

-0.97 (-2.42%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Recommendations
HD Supply analyst commentary  »

HD Supply price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$279.48

-0.26 (-0.09%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$313.58

-0.29 (-0.09%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNQ

Canadian Natural

$29.51

0.4524 (1.56%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Upgrade
Canadian Natural rating change  »

Canadian Natural upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

XLF

Financial Select Sector

$30.28

(0.00%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$133.61

0.51 (0.38%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$203.90

-0.13 (-0.06%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$68.90

-0.73 (-1.05%)

, T

AT&T

$38.07

0.025 (0.07%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Conference/Events
Barclays to hold a conference »

Global Technology, Media…

LITE

Lumentum

$68.90

-0.73 (-1.05%)

T

AT&T

$38.07

0.025 (0.07%)

GLW

Corning

$28.00

-0.5 (-1.75%)

AIC

Aames Investment

$23.46

0.055 (0.24%)

AMD

AMD

$39.44

0.53 (1.36%)

NOW

ServiceNow

$266.94

-2.95 (-1.09%)

ADSK

Autodesk

$178.50

-0.28 (-0.16%)

PEGA

Pegasystems

$75.42

-0.81 (-1.06%)

TXN

Texas Instruments

$121.38

-0.61 (-0.50%)

ALRM

Alarm.com

$41.80

-1.11 (-2.59%)

ESTC

Elastic

$62.46

0.32 (0.51%)

FICO

Fair Isaac

$354.61

-4.75 (-1.32%)

RVLV

Revolve Group

$17.02

-0.14 (-0.82%)

ZS

Zscaler

$46.10

-1.24 (-2.62%)

MOBL

MobileIron

$4.54

-0.045 (-0.98%)

AVLR

Avalara

$72.00

-0.84 (-1.15%)

VMW

VMware

$148.73

-0.78 (-0.52%)

CCC

Clarivate Analytics

$16.90

-0.17 (-1.00%)

MSFT

Microsoft

$151.18

-0.17 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 16

    Dec

  • 16

    Dec

  • 08

    Jan

  • 10

    Jan

  • 29

    Jan

  • 05

    Mar

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PMBC

Pacific Mercantile Bancorp

$7.19

0.06 (0.84%)

08:19
12/11/19
12/11
08:19
12/11/19
08:19
Hot Stocks
Pacific Mercantile Bank provides financing to Mako Steel »

Pacific Mercantile Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$84.11

-0.83 (-0.98%)

, AAPL

Apple

$268.62

1.69 (0.63%)

08:18
12/11/19
12/11
08:18
12/11/19
08:18
Recommendations
Qualcomm, Apple analyst commentary  »

BofA says Apple could…

QCOM

Qualcomm

$84.11

-0.83 (-0.98%)

AAPL

Apple

$268.62

1.69 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

DARE

Dare Bioscience

$0.80

-0.0087 (-1.08%)

08:15
12/11/19
12/11
08:15
12/11/19
08:15
Hot Stocks
Dare announces alignment with FDA on Phase 2b study of Sildenafil Cream »

Dare Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
12/11/19
12/11
08:15
12/11/19
08:15
General news
CPI to be reported at 08:30 »

November CPI will be…

08:15
12/11/19
12/11
08:15
12/11/19
08:15
General news
CPI less food & energy- to be reported at 08:30 »

November CPI less food…

ITRM

Iterum Therapeutics

$4.90

1.1 (28.95%)

08:14
12/11/19
12/11
08:14
12/11/19
08:14
Recommendations
Iterum Therapeutics analyst commentary  »

Iterum Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$13.70

-0.685 (-4.76%)

08:14
12/11/19
12/11
08:14
12/11/19
08:14
Conference/Events
Yext management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

KLR

Kaleyra

$8.49

0.03 (0.35%)

08:11
12/11/19
12/11
08:11
12/11/19
08:11
Initiation
Kaleyra initiated  »

Kaleyra initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WINT

Windtree Therapeutics

$0.00

(0.00%)

08:11
12/11/19
12/11
08:11
12/11/19
08:11
Conference/Events
Windtree Therapeutics to hold a financial update »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTM

Constellium

$14.50

0.06 (0.42%)

08:11
12/11/19
12/11
08:11
12/11/19
08:11
Hot Stocks
Constellium's Singen facility to offer ASI certified aluminum rolled solutions »

Constellium SE announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.